Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
5,800
Employees5,800
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
5,800
Employees5,800

MRNA Key Statistics

Market cap
9.45B
Market cap9.45B
Price-Earnings ratio
-3.00
Price-Earnings ratio-3.00
Dividend yield
Dividend yield
Average volume
9.52M
Average volume9.52M
High today
$25.45
High today$25.45
Low today
$24.13
Low today$24.13
Open price
$25.06
Open price$25.06
Volume
9.61M
Volume9.61M
52 Week high
$48.92
52 Week high$48.92
52 Week low
$22.28
52 Week low$22.28

Stock Snapshot

The current Moderna(MRNA) stock price is $24.27, with a market capitalization of 9.45B. The stock trades at a price-to-earnings (P/E) ratio of -3.00.

During the trading session on 2025-12-01, Moderna(MRNA) shares reached a daily high of $25.45 and a low of $24.13. At a current price of $24.27, the stock is +0.6% higher than the low and still -4.6% under the high.

Trading activity shows a volume of 9.61M, compared to an average daily volume of 9.52M.

The stock's 52-week range extends from a low of $22.28 to a high of $48.92.

The stock's 52-week range extends from a low of $22.28 to a high of $48.92.

MRNA News

Benzinga 8h
What's Going On With Moderna Stock Monday?

Shares of Moderna, Inc. (NASDAQ:MRNA) , along with other vaccine stocks, are trading lower Monday following reports indicating Center for Biologics Evaluation a...

Analyst ratings

65%

of 26 ratings
Buy
19.2%
Hold
65.4%
Sell
15.4%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.